Summary of Purpose
The burden of non-disabling ischemic cerebrovascular events (NICE) is significantly increased. In order to achieve accurate risk stratification and effective treatments, developing new diagnostic, therapeutic, and prognostic strategies is indispensable. Chinese registry of NICE is a national multi-center prospective study aimed to explore the epidemiology, new biomarkers, risk factors and prognostic models.Read More →
The following dates are available for this trial. Trial information last updated on 9 May 2017.
|1 Jun 2017||9 Mar 2017||1 Feb 2019||1 Feb 2020||1 May 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Yuming Xu, MD, PhD
- Yilong Wang, MD, PhD